AU2001261007A1 - Compositions and methods for the therapy and diagnosis of lung cancer - Google Patents
Compositions and methods for the therapy and diagnosis of lung cancerInfo
- Publication number
- AU2001261007A1 AU2001261007A1 AU2001261007A AU6100701A AU2001261007A1 AU 2001261007 A1 AU2001261007 A1 AU 2001261007A1 AU 2001261007 A AU2001261007 A AU 2001261007A AU 6100701 A AU6100701 A AU 6100701A AU 2001261007 A1 AU2001261007 A1 AU 2001261007A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- therapy
- compositions
- methods
- lung cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53803700A | 2000-03-29 | 2000-03-29 | |
US09/538,037 | 2000-03-29 | ||
US58893700A | 2000-06-05 | 2000-06-05 | |
US09/588,937 | 2000-06-05 | ||
US64087800A | 2000-08-18 | 2000-08-18 | |
US09/640,878 | 2000-08-18 | ||
US23451700P | 2000-09-22 | 2000-09-22 | |
US60/234,517 | 2000-09-22 | ||
US70451200A | 2000-11-01 | 2000-11-01 | |
US09/704,512 | 2000-11-01 | ||
US09/738,973 US20020110563A1 (en) | 2000-11-01 | 2000-12-14 | Compositions and methods for the therapy and diagnosis of lung cancer |
US09/738,973 | 2000-12-14 | ||
PCT/US2001/009991 WO2001072295A2 (en) | 2000-03-29 | 2001-03-28 | Compositions and methods for the therapy and diagnosis of lung cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001261007A1 true AU2001261007A1 (en) | 2001-10-08 |
Family
ID=27559252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001261007A Abandoned AU2001261007A1 (en) | 2000-03-29 | 2001-03-28 | Compositions and methods for the therapy and diagnosis of lung cancer |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2004526401A (en) |
AU (1) | AU2001261007A1 (en) |
CA (1) | CA2404233A1 (en) |
CZ (1) | CZ20023567A3 (en) |
HU (1) | HUP0500345A2 (en) |
PL (1) | PL366626A1 (en) |
WO (1) | WO2001072295A2 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020082212A1 (en) * | 2000-07-20 | 2002-06-27 | Millennium Pharmaceuticals, Inc. | 7716, a novel human ATPase and uses therefor |
AU2002311909A1 (en) * | 2001-05-11 | 2002-11-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US20040081653A1 (en) | 2002-08-16 | 2004-04-29 | Raitano Arthur B. | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
US7718787B2 (en) * | 2002-10-18 | 2010-05-18 | Lg Life Sciences Limited | Gene families associated with cancers |
DE10258051A1 (en) * | 2002-12-11 | 2004-07-22 | Metagen Pharmaceuticals Gmbh | Use of substances that bind to HAT for the diagnosis and treatment of squamous cell carcinoma of the lungs |
WO2004055183A2 (en) * | 2002-12-17 | 2004-07-01 | Fondazione Centro San Raffaele Del Monte Tabor | Carcinoembryonic antigen-specific immunodominant epitope recognized by cd4+t cells and uses thereof |
EP1577323B1 (en) | 2002-12-26 | 2013-07-10 | Takeda Pharmaceutical Company Limited | Metastin derivative and use thereof |
CA2571420A1 (en) | 2004-06-25 | 2006-01-05 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
GB0512401D0 (en) * | 2005-06-17 | 2005-07-27 | Randox Lab Ltd | Method |
US8404643B2 (en) | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
AR058584A1 (en) | 2005-12-22 | 2008-02-13 | Takeda Pharmaceutical | METASTININE DERIVATIVES AND USE OF THE SAME |
JP2007263896A (en) * | 2006-03-29 | 2007-10-11 | Univ Nagoya | Biological marker for estimating post-operative prediction of lung cancer patient, and method therefor |
TWI404726B (en) | 2006-10-25 | 2013-08-11 | Takeda Pharmaceutical | Metastin derivatives and use thereof |
JP5648261B2 (en) * | 2006-12-20 | 2015-01-07 | 東レ株式会社 | Cancer detection method |
ES2502940T3 (en) | 2008-08-05 | 2014-10-06 | Toray Industries, Inc. | Pharmaceutical composition for the treatment and prevention of cancer |
PL2325648T3 (en) * | 2008-08-05 | 2014-09-30 | Toray Industries | Method for detecting cancer |
TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
NZ592461A (en) | 2008-10-22 | 2012-12-21 | Oncotherapy Science Inc | Rab6kifl/kif20a epitope peptide and vaccines containing the same |
PT2532680E (en) | 2010-02-04 | 2015-09-14 | Toray Industries | Medicinal composition for treating and/or preventing cancer |
HUE030102T2 (en) | 2010-02-04 | 2017-04-28 | Toray Industries | Pharmaceutical composition comprising anti caprin-1 antibodies for treating and/or preventing cancer |
CN102822335B (en) | 2010-02-04 | 2015-09-30 | 东丽株式会社 | Cancer treat and/or prevent pharmaceutical composition |
US8937160B2 (en) | 2010-02-04 | 2015-01-20 | Toray Industries, Inc. | Pharmaceutical composition for treating and/or preventing cancer |
PL2532365T3 (en) | 2010-02-04 | 2016-12-30 | Pharmaceutical composition for treatment and/or prevention of cancer | |
KR101843807B1 (en) | 2010-02-04 | 2018-03-30 | 도레이 카부시키가이샤 | Pharmaceutical agent for treatment and/or prevention of cancer |
EP2740798B1 (en) | 2011-08-04 | 2016-12-07 | Toray Industries, Inc. | Cancer treatment and/or prevention drug composition |
US9273128B2 (en) | 2011-08-04 | 2016-03-01 | Toray Industries, Inc | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
TR201802089T4 (en) | 2011-08-04 | 2018-03-21 | Toray Industries | Drug composition for the treatment and / or prevention of cancer. |
BR112014002619A2 (en) | 2011-08-04 | 2018-10-09 | Toray Industries, Inc | pharmaceutical composition and method of treatment and / or prevention of pancreatic cancer and pharmaceutical combination |
WO2013018889A1 (en) | 2011-08-04 | 2013-02-07 | 東レ株式会社 | Cancer treatment and/or prevention drug composition |
WO2013018885A1 (en) | 2011-08-04 | 2013-02-07 | 東レ株式会社 | Method for detecting pancreatic cancer |
JP6065590B2 (en) | 2011-08-04 | 2017-01-25 | 東レ株式会社 | Pharmaceutical composition for treatment and / or prevention of cancer |
ES2749672T3 (en) | 2012-02-21 | 2020-03-23 | Toray Industries | Pharmaceutical composition to treat and / or prevent cancer |
KR102009236B1 (en) | 2012-02-21 | 2019-08-09 | 도레이 카부시키가이샤 | Pharmaceutical composition for treatment and/or prevention of cancer |
BR112014021101A2 (en) | 2012-02-21 | 2022-03-22 | Toray Industries | Antibody, pharmaceutical composition, combination drug, DNA and method of treating and/or preventing cancer, use of an antibody |
BR112014021102A2 (en) | 2012-02-21 | 2021-12-28 | Toray Ind Inc | Antibody, pharmaceutical composition, combination drug, dna, treatment method and use of antibody |
RU2640245C2 (en) | 2012-03-30 | 2017-12-27 | Торэй Индастриз, Инк. | Pharmaceutical composition for liver cancer treatment and/or prevention |
DK2832366T3 (en) | 2012-03-30 | 2018-01-22 | Toray Industries | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR PREVENTION OF Gallbladder cancer |
KR102056654B1 (en) | 2012-07-19 | 2019-12-17 | 도레이 카부시키가이샤 | Cancer detection method |
CA2879185C (en) | 2012-07-19 | 2021-08-24 | Toray Industries, Inc. | Method for detecting cancer |
KR102255616B1 (en) | 2013-08-09 | 2021-05-25 | 도레이 카부시키가이샤 | Pharmaceutical composition for treatment and/or prevention of cancer |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589579A (en) * | 1994-07-19 | 1996-12-31 | Cytoclonal Pharmaceutics, Inc. | Gene sequence and probe for a marker of non-small cell lung carinoma |
WO2001057188A2 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
EP1187915A2 (en) * | 1999-04-02 | 2002-03-20 | Corixa Corporation | Compounds for therapy and diagnosis of lung cancer and methods for their use |
EP1278841A2 (en) * | 2000-04-17 | 2003-01-29 | PHARMACIA & UPJOHN COMPANY | G protein-coupled receptor |
WO2001083553A2 (en) * | 2000-05-03 | 2001-11-08 | Pharmacia & Upjohn Company | G protein-coupled receptors |
JP2004512023A (en) * | 2000-06-09 | 2004-04-22 | コリクサ コーポレイション | Compositions and methods for treatment and diagnosis of colon cancer |
-
2001
- 2001-03-28 CZ CZ20023567A patent/CZ20023567A3/en unknown
- 2001-03-28 JP JP2001570256A patent/JP2004526401A/en active Pending
- 2001-03-28 AU AU2001261007A patent/AU2001261007A1/en not_active Abandoned
- 2001-03-28 WO PCT/US2001/009991 patent/WO2001072295A2/en active Application Filing
- 2001-03-28 PL PL01366626A patent/PL366626A1/en not_active Application Discontinuation
- 2001-03-28 CA CA002404233A patent/CA2404233A1/en not_active Abandoned
- 2001-03-28 HU HU0500345A patent/HUP0500345A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2001072295A2 (en) | 2001-10-04 |
CA2404233A1 (en) | 2001-10-04 |
PL366626A1 (en) | 2005-02-07 |
CZ20023567A3 (en) | 2003-11-12 |
JP2004526401A (en) | 2004-09-02 |
WO2001072295A3 (en) | 2002-08-22 |
HUP0500345A2 (en) | 2005-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
PL354093A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002218770A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2002311909A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002251841A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
AU2002251844A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU4185100A (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
AU2002254482A1 (en) | Compositions and methods for the therapy and diagnosis of kidney cancer | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002359330A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2002239431A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU2001273149A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU5638400A (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU2003230849A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001273127A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001271284A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer |